Genetic diversity plays a central role in tumor progression, metastasis, and resistance to treatment. Experiments are shedding light on this diversity at ever finer scales, but interpretation is challenging. Using recent progress in numerical models, we simulate macroscopic tumors to investigate the interplay between growth dynamics, microscopic composition, and circulating tumor cell cluster diversity. We find that modest differences in growth parameters can profoundly change microscopic diversity. Simple outwards expansion leads to spatially segregated clones and low diversity, as expected. However, a modest cell turnover can result in an increased number of divisions and mixing among clones resulting in increased microscopic diversity in the tumor core. Using simulations to estimate power to detect such spatial trends, we find that multi-region sequencing data from contemporary studies is marginally powered to detect the predicted effects. Slightly larger samples, improved detection of rare variants, or sequencing of smaller biopsies or circulating tumor cell clusters would allow one to distinguish between leading models of tumor evolution. The genetic composition of circulating tumor cell clusters, which can be obtained from noninvasive blood draws, is therefore informative about tumor evolution and its metastatic potential.
Introduction
Most cancer deaths are due to metastasis of the primary tumor, which complicates treatment and promotes relapse (Holohan et al. 2013; Quail and Joyce 2013; Vanharanta and Massagu e 2013; Steeg 2016) . Circulating tumor cells (CTC) are bloodborne enablers of metastasis that were first detected in the blood of patients after death (Ashworth 1869) and can now be captured using a variety of devices (Glynn et al. 2015; Joosse et al. 2015; Sarioglu et al. 2015; Siravegna et al. 2017) allowing us to study their origins and implications for metastasis (Massagu e and Obenauf 2016; Lambertet al. 2017) . Counts of single CTCs have been used to predict tumor progression (Cristofanilli et al. 2005; Krebs et al. 2011; Siravegna et al. 2017 ) and monitor curative and palliative therapies in a vast array of cancer types (Hayes et al. 2002; Wülfing et al. 2006; Aceto et al. 2015; Siravegna et al. 2017) . CTCs have also been isolated in clusters of up to 100 cells (Marrinucci et al. 2012; Aceto et al. 2014; Glynn et al. 2015; Au et al. 2017) . These CTC clusters, though rare, are associated with more aggressive metastatic cancer and poorer survival rates in mice and breast and prostate cancer patients (Liotta et al. 1976; Glaves 1983; Aceto et al. 2014; Cheung et al. 2016) .
Cellular growth within tumors follows Darwinian evolution with sequential accumulation of mutations and selection resulting in subclones of different fitness (Nowell 1976; Burrell et al. 2013; Williams et al. 2016) . Certain classes of mutations are known to give cancer cells advantages beyond local growth rates. For example, acquiring mutations in ANGPTL4 in breast tumors does not appear to provide a growth advantage to cells in the primary, however it enhances metastatic potential to the lungs (Padua et al. 2008) . Similarly, breast tumors are more likely to metastasize into the lung or brain if they acquire mutations in TGFa or ST6GALNAC5, respectively (Padua et al. 2008; Bos et al. 2009; Peinado et al. 2017) . These genes are referred to as metastasis progression genes or metastasis virulence genes (Lorusso and Rüegg 2012) .
Mutations, including those in metastasis progression and virulence genes, are not uniformly distributed in the tumor. Tumors show substantial intratumoral heterogeneity (ITH) (Navin et al. 2010; Gerlinger et al. 2012; Sottoriva et al. 2015; Swanton 2015, 2017) where subclones have private mutations that can lead to subclonal phenotypes (Gerlinger et al. 2014; Zhang et al. 2014; Yates et al. 2015; Morrissy et al. 2017; Peinado et al. 2017) . A high degree of ITH can allow tumors to explore a wide range of phenotypes relevant to metastatic outlook. Additionally, ITH can contribute to therapy resistance and relapse (Holohan et al. 2013; Hiley et al. 2014 ). Studying ITH is therefore important for understanding cancer progression and improving therapeutic and prognostic decisions (Hiley et al. 2014; Jamal-Hanjani et al. 2014; Alizadeh et al. 2015; Andor et al. 2016) . To capture the complete mutational spectrum of a primary tumor, multiple study designs have been proposed that divide the tumor into regionally representative samples, known as multi-region sequencing (Gerlinger et al. 2012 (Gerlinger et al. , 2014 Zhang et al. 2014; Ling et al. 2015; Yates et al. 2015) . Such regional characterizations can be used to distinguish between growth models (Sun et al. 2017) .
Next-generation sequencing (NGS) and molecular profiling has shown that CTCs have similar genetic composition to both the primary and metastatic lesions (Heitzer et al. 2013; Brouwer et al. 2016; Siravegna et al. 2017) . Sequencing of CTCs can therefore be used as a noninvasive liquid biopsy to study tumors and tumor heterogeneity, monitor response to therapy, and determine patient-specific course of treatment (Powell et al. 2012; Heitzer et al. 2013; Hodgkinson et al. 2014; Krebs et al. 2014) .
Here, we use simulations to assess whether genetic heterogeneity within individual circulating tumor cell clusters can be informative about solid tumor progression. Because CTC clusters are thought to originate from neighboring cells in the tumor (Aceto et al. 2014) , heterogeneity within CTC clusters is closely related to cellular-scale genetic heterogeneity within tumors. We therefore interpret our simulation results as informative about both microbiopsies and circulating tumor cell clusters.
We used an extension (https://github.com/zafarali/tumorheterogeneity, last accessed June 10, 2018) of the simulator described in Waclaw et al. (2015) to study the interplay of tumor dynamics, CTC cluster diversity, and metastatic outlook. We first consider tumor-wide heterogeneity patterns, and find that the overall distribution of common allele frequencies is well described by a recent analytical model of tumor growth (Fusco et al. 2016 ) that assumes neutrality and no turnover: the global patterns of diversity are relatively robust to modest departures from these assumptions. We then show that finescale tumor heterogeneity, and therefore CTC cluster composition, depend more sensitively on the turnover dynamics of the tumor. We discuss consequences for metastatic outlook and, by simulating multi-region sequencing studies of microbiopsies, show that currently achievable sample sizes would be well powered to identify spatial trends and distinguish between leading models of tumor evolution.
Simulation Model
To simulate the growth of solid tumors, we use TumorSimulator (https://www2.ph.ed.ac.uk/$bwaclaw/cancer-code/, last accessed June 10, 2018) (Waclaw et al. 2015) .
The software is able to simulate a tumor containing 10 8 cells, or roughly 1 cubic centimeter (Del Monte 2009), in <24 corehours. The tumor consists of cells that occupy points on a 3D lattice. Cells do not move in this model: The tumor evolves through cell division and death. Empty lattice sites are assumed to contain normal cells which are not modelled in TumorSimulator.
Each cell has an associated list of genetic alterations which represent single nucleotide polymorphisms (SNPs) that can be either passenger or driver. Driver mutations increase the growth rate by a factor 1 þ s, where s >= 0 is the average selective advantage of a driver mutation.
The simulation begins with a single cell that already has an unlimited growth potential. Tumor growth then proceeds by selecting a mother cell randomly. It then divides with a probability proportional to b 0 ð1 þ sÞ k (rescaled by the maximal birth rate of all cells in the tumor, such that this probability is 1) where b 0 is the inital birth rate and k is the number of driver mutations in that cell. New cells are given new passenger and driver mutations according to two independent Poisson distributions parameterized by haploid mutation rates l p and l d so that the maximal frequency in a tumor is one. The mother cell dies with a probability proportional to the death rate d (rescaled in a similar manner as the birth rate), independent of whether it succesfully reproduced. The simulation ends when there are 10 8 cells in the tumor, unless otherwise specified. To facilitate comparison, we first set parameters b 0 , s, l p , and l d to match those used in Waclaw et al. (2015) . When comparing to experimental data in Ling et al. (2015) , we adjust the passenger mutation rate to match empirical observations (See further details of the algorithm and complete description of parameters in Supplementary Material and supplementary table S2, Supplementary Material online, respectively).
We consider three turnover scenarios corresponding to three models for the death rate d: 1) No turnover (d ¼ 0), corresponding to simple clonal growth (Hallatschek et al. 2007; Fusco et al. 2016) ; 2) Surface Turnover (d(x, y, z) > 0 only if x, y, z is on the surface), corresponding to a quiescent core model (Shweiki et al. 1995) ; and 3) Turnover (d > 0 everywhere), a model favored in Waclaw et al. (2015) to explore ITH.
Results

Global Composition
To determine the effect of the growth dynamics on global intratumor heterogeneity, we first consider the distribution of allele frequencies (or allele frequency spectra, AFS) for different turnover models ( fig. 1 and supplementary fig. S1 , Supplementary Material online). In all cases, a majority of driver and passenger genetic variants are at frequency <1%, as expected from theoretical and empirical observations (e.g., Wang et al. 2014; Fusco et al. 2016; Sun et al. 2017 Ahmed and Gravel . doi:10.1093/molbev/msy115 (Williams et al. 2016; Niida et al. 2018) . For simulations with low to moderate death rate, d 2 {0.05, 0.1, 0.2} and s ¼ 1%, we find that the frequency spectra are very similar across the three turnover models ( fig. 1 and supplementary figs. S1 and S2, Supplementary Material online): A low death rate has little impact on the global composition of a tumor. When the death rate is increased to d¼ 0.65, as in Waclaw et al. (2015) , the different models produce distinct frequency spectra ( fig. 1b) . Waclaw et al. (2015) considered the number of high-frequency driver mutations as a measure of diversity, which is a simple summary statistic of the AFS. As in Waclaw et al., we find that the number of high-frequency drivers is higher in the turnover model than in the no turnover model. Waclaw et al. interpreted this observation as an indication that turnover reduces diversity, because high frequencies suggest a larger number of dominant clones. However, we find that diversity, as measured by the number of polymorphic sites, is in fact increased for all types of variants and at all frequencies. The number of somatic mutations in the turnover model is 3.4 times higher than in the surface turnover model and 6.2 times higher than in the no turnover model. This is primarily due to a higher number of cell divisions required to reach a given tumor size when cell death occurs throughout the tumor (supplementary table S1, Supplementary Material online). The Waclaw et al. model uses a death rate of d¼ 0.65, which is a staggering 95% of the birth rate. The turnover model therefore has 8.3 times more cell divisions to reach a given size, and the surface turnover has four times more cell divisions than the no turnover model (supplementary table S1, Supplementary Material online). Figure 1a exhibits two distinct power-law behaviors, a high-frequency power-law distribution /(f) of mutations
, and a low-frequency scaling as
. This scaling is present in the neutral case with no turnover (supplementary fig. S2a , Supplementary Material online). Scaling laws in the distribution of allele frequencies have attracted considerable interest, harking back to the Wright-Fisher model for a constant-sized population (the "standard neutral model") which predicts /(f) $ f -1 (Wright 1931; Fisher 1999) . Population growth leads to an excess of rare variants: Tumor models that account for exponential population growth in a coalescent or branching process framework (Ohtsuki and Innan 2017) 
, depending on model parameters. A more directly applicable theoretical model was developed in Fusco et al. (2016) to model outwards growth of a bacterial colony or tumor, without turnover. Based on experimental and simulation data, also showing two scaling regimes, Fusco et al. considered a low-frequency regime containing "bubbles" (mutations that are cut off from the surface) and a highfrequency regime consisting of "sectors" (mutations that kept on with surface growth). They then used a KardarParisi-Zhang model (Kardar et al. 1986 ) of surface growth that predicts scaling laws of /(f) $ f -1.55 at low frequencies, and of /(f) $ f -3.3 at high frequencies (assuming a rough tumor surface). Supplementary section S5, Supplementary Material online also provides a simplified deterministic and neutral geometric model for sectors which predicts a decay for common variants /(f) $ f FIG. 1. Frequency Spectra for the Primary Tumor at (a) low death rate and (b) high death rate for all mutations (circles) and driver mutations (triangles). At low death rate, the frequency spectra are nearly indistinguishable, whereas for higher death rate, the turnover model produces elevated diversity across the frequency spectrum for both driver and neutral mutations. The total number of somatic mutations, S, and the total number of driver mutations, fitting parameters ( fig. 1) . However, some departures are visible at extremely low frequencies (supplementary fig. S4a , Supplementary Material online). Even though the Fusco et al. model assumes no turnover, it is relatively robust to modest turnover. For do¼ 0.2, there is a 20% increase of the overall number of segregating sites, but no difference in the overall scaling of common variants (supplementary fig. S2, Supplementary Material online) . Even in the large turnover regime (d=0.65), the two distinct scaling laws are still clearly visible, suggesting that the distinction between bubbles and sectors is a useful construct despite the massive turnover. Similarly, selection has a weak effect on global patterns of passenger diversity except under the presence of extremely strong turnover (supplementary fig. S2 
Cluster Diversity Depends on Sampling Position and Turnover Rate
To study the effect of cluster size, position of origin, and evolutionary model on CTC cluster composition, we sampled groups of cells across tumors (More details in Supplementary Section, Supplementary Material online, "CTC cluster synthesis"). To assess genetic heterogeneity within clusters, we consider the number of distinct somatic mutations, S(n), among cells in clusters of size n.
As expected, we find that larger CTC clusters have more somatic mutations ( fig. 2 and supplementary fig. S5 , Supplementary Material online). Whereas moderate turnover had little impact on the tumor-wide number or frequency distribution of segregating sites, it can lead to a 5-fold increase in the number of segregating sites observed in small clusters: Clusters from models with low turnover have many more somatic mutations than in the no turnover model ( fig. 2a  and b ). Surface turnover with low death rates d 2 {0, 0.05, 0.1, 0.2} has little effect on cluster diversity (supplementary fig. S5 , Supplementary Material online).
Figure 2 also shows the relationship between a CTC clusterlu shedding location (i.e., its distance to the tumor centerof-mass when it was sampled) and its genetic content. No turnover and surface turnover models show similar trends of increasing diversity with distance (supplementary fig. S5 , Supplementary Material online). Full turnover models show an opposite trend of decreasing diversity with distance in clusters of intermediate size ( fig. 2b-d and supplementary  fig. S6 , Supplementary Material online for d=0.1,. . . and 0.65, respectively).
The number of distinct somatic mutations per cluster S(n) shows a dip near the tumor surface where the cell density has not yet reached equilibrium ( fig. 2 and supplementary fig. S6,  Supplementary Material online) . This is the result of two transient effects. First, the earliest cells to populate the expansion front have experienced fewer divisions than the later cells, thus the average number of mutations in cells at a given distance from the tumor center increases as the front progresses. Second, the cells that first populate empty areas in the expansion front are more closely related to each other: If a cell has only one neighbor, it must descend directly from that neighbor; if a cell has 26 neighbors, it only has a 1/26 chance of descending directly from any given immediate neighbor-the time to the most recent common ancestor between neighbors increases as space fills up. Supplementary figure S8, Supplementary Material online, which shows how S(n) changes as the tumor expands from size 10 6 to 10 8 , also shows that this dip travels with the expansion front.
Supplementary figure S8 , Supplementary Material online, also shows how S(n) changes within the core of the tumor as it expands to eventually generate the patterns seen in figure 2. Two processes increase cluster diversity within the core: new mutations and mixing among existing clones. To disentangle the effect of these two processes, we produce an equivalent time-course simulation where new mutations are turned off when the tumor reaches 10 6 cells, leaving only clone mixing to increase genetic diversity. Supplementary figure S9, Supplementary Material online shows contrasting effects in the core and edge of the tumor: the diversity in edge clusters decreases over time because of serial founder effects. By contrast, the number of somatic mutations in clusters near the center of the tumor increases: Mixing causes an increase in the number of distinct somatic mutations present in a cluster of a given size by bringing together cells from more distant backgrounds, increasing the effective population size. This leads to a roughly linear increase of cluster diversity with distance from the tumor edge. For d=0.1 and clusters of 20 cells, the number of somatic mutations at the tumor center increases from 5 to 8 as the tumor grows from 10 6 to 10 8 cells (supplementary fig. S9, Supplementary Material online) . The number of somatic mutations further increases to 13 if mutations are allowed in the core of the tumor (supplementary fig.  S8 , Supplementary Material online): new mutations in this case contribute more to diversity in the core than clonal mixing.
Supplementary figure S10, Supplementary Material online, show an alternate representation of this effect: we visualize the coalescence trees for neighbourhoods of 30 cells at the center and edges of the tumor. Neighbourhoods near the center of the tumor have longer terminal branches as there was more time for additional mutations to accumulate. This effect is particularly pronounced as the death rate increases. Neighbourhoods near the edge share a larger proportion of the trunk indicating that the cells have a recent common ancestor as a consequence of the serial founder effect: the height of the trees are higher at the edge, but the sum of branch lengths (i.e., S(n)) are higher in the center for the turnover model.
Comparison with Multi-Region Sequencing Data
We did not have access to large-scale sequencing data for microbiopsies. To illustrate predictions of our model, we therefore used multi-region sequencing data from a Hepatocellular Carcinoma (HCC) patient presented in Ling et al. (2015) (fig. 3a) . The HCC data contained 23 sequenced samples from a single tumor each with % 20,000 cells. We therefore used our sampling scheme to simulate 23 biopsies of comparable sizes (20,000 cells). The distance measurements were made using ImageJ (Schneider et al. 2012 ) and supplementary figure S1, Supplementary Material online from Ling et al. (2015) . Since Ling et al. (2015) could only reliably call variants at >10% frequency, we used a similar frequency cutoff in our simulations. The HCC data does not show a clear spatial trend ( fig. 3a) whereas simulations with and without turnover had detectable trends at comparable sample size ( fig. 3c and d) .
We therefore investigated the study design that would be needed to effectively distinguish between the different models proposed here. Based on simulations, power depends on cluster size, number of clusters sampled, and the choice of frequency cutoff ( fig. 3b and supplementary fig. S11 , Supplementary Material online). For a sample of 23 biopsies with %20,000 cells each and a frequency cutoff of > 10%, we only have 50% power to detect a spatial trend in both turnover and no turnover models (supplementary fig. S11 , Supplementary Material online).
Spatial trends observed in figure 2 and supplementary fig.  S5 , Supplementary Material online, are barely detectable with the current sample size but could be detected with modest increases in sample size or decreases in the frequency cutoff ( fig. 3b) . The choice of frequency cutoff can qualitatively affect spatial trends. Biopsies containing tens of thousands of cells with a 10% frequency cutoff show an increase in diversity at the edge of the tumor across all turnover models, with the number of spatially distributed samples needed to detect the trend reliably close to 40, roughly twice the size of the HCC data set. If all mutations could be reliably detected, including at frequencies below 1%, spatial patterns should be apparent with only ten biopsies, and these would highlight qualitative differences between the models, with increased diversity in the core for turnover models (supplementary fig. S11 , Supplementary Material online).
Small cluster sequencing, by focusing on globally rare but locally common variation, easily captures such differences in growth models. Approximately 30 deep sequenced small cluster (23-30 cells) samples are sufficient to reliably reveal qualitative difference between turnover models that neither single cells nor large biopsies capture, even at low (1%) frequency cutoffs (supplementary fig. S11 , Supplementary Material online).
CTC Clusters Derived from Turnover Models Are More Likely to Contain Virulent Mutations
Metastasis is an inefficient process (Massagu e and Obenauf 2016) in that most CTCs are eliminated from the circulatory system or fail to survive in the new microenvironment. We hypothesize that the genetic composition of CTC clusters influences the likelihood of implantation into a new microenvironment. More specifically, genetic heterogeneity within a cluster may contribute to implantation by increasing the likelihood that a metastasis progression mutation is present. If a cluster has S somatic mutations, and each mutation has a small probability p ( 1 of being a metastasis progression or virulence gene, the probability of having at least one such metastasis virulence gene is 1 À ð1 À pÞ S % Sp. Diverse CTC clusters do not carry more virulent mutations, on average, than homogeneous ones, but they are more likely to carry some virulent mutations because of the increased diversity. Unless implantation probability is exactly proportional to the number of cells carrying virulent mutations in a cluster, which seems unlikely, diversity will impact implantation rate.
To compare the increased likelihood that CTC clusters possess metastatic progression genes compared with single CTCs, we determine the relative increase in the number of distinct somatic mutations in a CTC cluster versus a single CTC and refer to it as the cluster advantage, A(n). To disentangle the contributions from the microscopic and macroscopic diversity, as well as cluster size effects, we compute the cluster advantage for clusters composed of neighboring cells, as well as for random sets of cells sampled across the tumor (fig. 4) .
Whereas randomly sampled sets of cells show similar and almost linear increase of the cluster advantage with sample size, cell clusters show more variability. Turnover models have the highest cluster advantage, followed by the surface turnover model, and the no turnover model (fig. 4 ). Higher 
Discussion
Global Diversity
Even though tumor-wide distribution of allele frequencies in our simulations are consistent with Waclaw et al. (2015) , we reach opposite conclusions about the effect of cell turnover on genetic diversity. Waclaw et al. argued that turnover reduces diversity based on the observation that more highfrequency variants were observed in the tumor with turnover: A small number of clones make up a larger proportion of the tumor. Even though we can reproduce the observation, we find that turnover models in fact vastly increase diversity according to more conventional metrics, for example by increasing the number of somatic mutations (by % 6.2Â for d=0.65) across the frequency spectrum. Both the increase in the number of dominant clonal mutations and the increased overall number of polymorphic sites have the same simple origin: A tumor model with turnover requires more cell divisions to reach a given size. Even though an early driver mutation has more time to realize a selective advantage and occupy a higher fraction of the tumor, carrier cells are also more likely to accumulate new mutations along the way leading to increased polymorphism ( fig. 1 and supplementary table S1, Supplementary Material online). In other words, the Waclaw et al. metric of diversity (i.e., the number of clones above 10% in frequency) can reflect a higher concentration of common clones, but it is also confounded by changes in the mutation rate or in the number of cell divisions (i.e., an increase in the neutral mutation rate would counterintuitively result in a reduced measure of diversity). At low rates of turnover, the global distribution of allele frequencies above 10 -4 is well described by the Fusco et al. model assuming neutrality without turnover. With low turnover, the tumor is almost completely occupied, weakening the effect of selection (supplementary fig. S2 , Supplementary Material online): favorable mutations trapped within the tumor are hindered by spatial constraints (Enriquez-Navas et al. 2016; Fusco et al. 2016) , whereas the effect of selection along the tumor edge is limited by the excess drift at the frontier (Excoffier et al. 2009 ). However, when turnover is increased to d¼ 0.65, the tumor is largely unoccupied (supplementary fig.  S6 , Supplementary Material online) allowing for the release of the growth potential in fitter clones in the core.
Spatial Patterns in Small Clusters
The impact of turnover on cellular heterogeneity is more pronounced when considering small cell clusters ( fig. 2 and  supplementary fig. S5, Supplementary Material online) . These fine-scale patterns can be interpreted by considering the expansion dynamics of each model and their impact on cell division and clonal mixing.
In all turnover models, the number of somatic mutations in a given cell is % 3.0Â higher at the edges than at the center of the tumor, reflecting the higher number of divisions to reach the edge: The center of the tumor is occupied early, which slows down cell division. Cells keep dividing due to turnover, however: For example, cells at the center of the tumor with d=0.2 have % 8.4 somatic mutations, compared with % 5.8 for the no turnover model. Turnover thus reduces, as expected, differences between edge and core cells: Without turnover, the number of somatic mutations per cell is % 4.2 times higher at the edge than in the core, and the ratio is reduced to % 2.0 when d=0.2.
In the no turnover and surface turnover models, cell clusters show the same overall pattern of additional diversity at tumor edge. In the turnover model, however, we observe the opposite pattern: Even though edge cells still carry the most mutations, core clusters are now much more diverse than edge clusters. This can be understood in terms of a competition between the number of cell divisions (higher at the edge) and the effective population size (higher in the center). Even weak turnover vastly increases effective population size in the core. Even though a full analytical treatment of the spatial distribution of diversity in small clusters is beyond the scope of this article, the excellent agreement of the Fusco et al. model predictions to global diversity patterns suggest that it provides an excellent starting point to build such a model. Supplementary sections S7, S8, and S9, Supplementary Material online provides simple order-of-magnitude estimate for the effects of clone mixing and late mutations (i.e., mutations in the core) observed on diversity patterns, including an extension of the Fusco et al. model that accounts for late mutations. In addition to turnover rate, a key parameter that controls mixing is the expected distance between mother and daughter cells. In TumorSimulator, cells are allowed to reproduce to neighboring positions according to a Moore neighborhood, which leads to relatively diffuse small clusters. A challenge in building models for fine-scale diversity will be to implement realistic models of cell-cell interactions ( fig. 5 ).
Metastatic Potential
The difference in somatic diversity between single CTCs and CTC clusters, measured through the cluster advantage, follows the expected law of diminishing returns: The more cells in the cluster, the fewer the number of unique mutations per cell. However, the trends vary by growth model and cluster origin. Cell mixing and rare, late mutations caused by turnover reduces neighboring cell similarity and increases cluster advantage.
Under the assumption that the presence or absence of a metastatic progression allele modulates metastatic potential of tumor cell clusters, the proportion of metastatic lesions that derive from circulating tumor cell clusters is highest in the turnover model. We can think of this as interference occurring between cells within a cluster. Alternately, this is an illustration of the advantage of not putting all onenl egg in the same basket, applied to tumor metastasis: Assuming that there is a chance component to cluster implantation, mixing due to turnover increases the likelihood that at least one virulence cell makes it to a hospitable site. Such an effect should be robust to details of the growth model.
In experiments, CTC clusters derived from primary breast and prostate tumors produced more aggressive metastatic tumors (Aceto et al. 2014 ) compared with single CTCs. This is likely due to differences in mechanical properties of the cluster or the creation of a locally favorable environment by the cluster, rather than by genetic differences. However, the present analysis suggests that this advantage can be enhanced by diversity within the cluster. 
Statistical Power
Both fine-scale mixtures of cell phenotypes and clonally constrained mutations have been observed experimentally in tumors (Navin et al. 2010; Yates et al. 2015) . Similarly, multi-region sequencing revealed high tumor heterogeneity in clear cell renal carcinoma (ccRCC) (Gerlinger et al. 2014) and esophageal squamous cell carcinoma (Hao et al. 2016 ), but low levels in lung adenocarcinomas (Zhang et al. 2014 ). This strongly suggests that the amount of mixing and late mutations varies substantially across tumors, with ccRCC data being better described by a model with turnover, whereas lung adenocarcinoma data more closely resembles a model with low or no turnover.
In practice, distinguishing between mixing, turnover, mutations, and tumor growth idiosyncrasies will be challenging. Among limitations of our model, we note the assumption of spherical tumor shape and the absence of complex physical contraints (which HCC tumors may experience). Another limitation of the present model is the rigid computational grid which prevents cells from pushing each other out of the way, which constrains growth in the center of the tumor. This constraint plays a role in reducing diversity at the center of the tumor, but it may not be realistic in the earlier stages of tumor growth.
The importance of such effects is largely unknown, and it is likely to vary between tumors and tumor types. Fortunately, we have shown that we are at the cusp of being able to test such models quantitatively. A sampling experiment with twice as many samples than were collected in the HCC patient studied above would enable us to either validate or reject the current state-of-the-art models confidently ( fig. 3b) . Alternatively, sequencing of small clusters would further allow us to discriminate between the different models of turnover.
In either case, the use of frequency cutoffs can strongly affect inferred spatial patterns of diversity: a focus on common variants means a focus on old branches of the tree (supplementary fig. S10, Supplementary Material online) . This emphasizes the mean number of divisions per cell, which is larger at the edge, but fails to capture recent mutations and clonal mixing, which have larger impact at the core. Thus, spatial patterns inferred using variants at frequency above 1% are more similar across models, and can be opposite to those including all mutations (supplementary fig. S11 , Supplementary Material online).
Data collection schemes including the lung TRACERx study (Jamal-Hanjani et al. 2014 , 2017 will help us put the state-of-the-art models to the test and identify such important parameters of tumor growth. Given our power analysis, we find that sequencing small contiguous cell clusters provides a richer picture of tumor dynamics compared with larger biopsies, with little to no loss in power, assuming that few-cell sequencing can be performed accurately. Our results complement (2017) who were able to make practical suggestions for the number of large samples to use in multiregion sequencing studies.
Conclusion
This work set out to answer two simple questions: First, should we expect substantial heterogeneity at the cellular scale within tumors and within circulating tumor cell clusters? The answer to the first question is most likely yes, as even the models with no turnover exhibit measurable cluster heterogeneity.
The second question was whether this heterogeneity, sampled through liquid biopsies or multi-region sequencing, is informative about tumor dynamics. Given that state-of-theart models produce very different predictions about the level of cluster heterogeneity, the answer is also positive. This work identified some of the key factors that determine cluster diversity, especially the interaction between range expansion and cell turnover leading to late mutations and mixing. Even if no diversity were observed at all in CTC clusters, it would enable us to reject the present models in favor of models including additional biological factors that favor the clustering of genetically similar cells. Measuring diversity, or the lack of diversity, within circulating tumor cell clusters or fine-scale multi-region sequencing is therefore a promising tool for both fundamental and medical oncology.
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